Remophos - 667 MG

Tablet

Pack Size : 10 Tablet x 1 Strip

Generics : Calcium Acetate

Manufacturer : ACI Limited

Best Price * TK 60.20

* Delivery will be done in Dhaka city only.

Alternative Product

Tablet Hypophos - 667mg Popular Pharmaceuticals Ltd.

Tk 5.52

More Information About - Remophos - 667 MG

Description

Generic Name

Calcium Acetate

Precaution

Patients undergoing chronic hemodialysis. Renal impairment, diseases associated with hypercalcaemia such as sarcoidosis & some malignancies. Avoid in patients with calcium renal calculi or a history of renal calculi. Maintenance of normal serum calcium levels is important for maternal and fetal well being; hypercalcemia during pregnancy may increase risk for maternal and neonatal complications(eg, stillbirth, preterm delivery, neonatal hypocalcemia and hypoparathyroidism);calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment Lactation: unknown

Indication

Hyperphosphatemia

Contra Indication

Patients with hypercalcaemia.

Dose

N/A

Side Effect

Arrhythmias,Hypomagnesemia,Hypophosphatemia,Hypotension,Nausea,Pruritus (rare),Weakness Hypercalcemia,Anorexia,Coma,Confusion,Delirium,Headache,Nausea,Vomiting

Pregnancy Category

Name : C

Description

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Mode of Action

Sequesters phosphate in the intestine by forming insoluble phosphates that are excreted faecally, thus reducing serum phosphate conc & secondary hyperparathyroidism.

Interaction

Tetracycline antibiotics, thiazide diuretics, vit D, corticosteroids, bisphosphonates, fluoride, some fluoroquinolones.

Pregnancy Category Note

Pregnancy Category: C Maintenance of normal serum calcium levels is important for maternal and fetal well being; hypercalcemia during pregnancy may increase risk for maternal and neonatal complications(eg, stillbirth, preterm delivery, neonatal hypocalcemia and hypoparathyroidism);calcium acetate treatment, as recommended, is not expected to harm a fetus if maternal calcium levels are properly monitored during and following treatment Lactation: unknown

Adult Dose

N/A

Child Dose

N/A

Renal Dose

N/A

Administration

Should be taken with food.

Disclaimer

The information provided herein are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please note that this information should not be treated as a replacement for physical medical consultation or advice. Great effort has been placed to provide accurate and comprehensive data. However, Medicart along with its authors and editors make no representations or warranties and specifically disclaim all liability for any medical information provided on the site. The absence of any information and/or warning to any drug shall not be considered and assumed as an implied assurance of the Company.